Epam, C.H. Robinson fall; Palo Alto Networks, Circor rise

→ Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad)

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:

3M Co., down $4.55 to $97.98.

The maker of office supplies, adhesives and medical products is reportedly close to settling a water pollution lawsuit in Florida.

Palo Alto Networks Inc., up $9.55 to $226.79.

The security software maker is replacing Dish Network in the S&P 500.

C.H. Robinson Worldwide Inc., down $6.27 to $91.40.

The trucking company is reportedly naming a Ford executive as its next CEO.

Circor International Inc., up $16.17 to $47.84.

Investment firm KKR is buying the maker of valves and other engineered products.

Amedisys Inc., up $12.27 to $91.74.

Optum is offering to buy the home health care and hospice services provider.

ImmunoGen Inc., up $1 to $15.37.

The drug developer gave investors an encouraging update on a potential ovarian cancer treatment.

Science Applications International Corp., up $1.20 to $102.65.

The information technology company raised its profit forecast for the year.

Epam Systems Inc., down $56.41 to $203.24

The information technology services provider cut its profit forecast for the year.

→ Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad)

Where should you invest $1,000 right now?

Before you make your next trade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.

They believe these five stocks are the five best companies for investors to buy now...

See The Five Stocks Here

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: